Pozzilli, Paolo.
Paolo Pozzilli researcher
Pozzilli, Paolo, 1951-
VIAF ID: 165254810 (Personal)
Permalink: http://viaf.org/viaf/165254810
Preferred Forms
- 100 0 _ ‡a Paolo Pozzilli ‡c researcher
-
- 100 1 _ ‡a Pozzilli, Paolo
-
-
-
- 100 1 _ ‡a Pozzilli, Paolo
- 100 1 _ ‡a Pozzilli, Paolo
-
- 100 1 _ ‡a Pozzilli, Paolo ‡d 1951-
-
-
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Atlas of endocrine and metabolic disease | |
Changing therapies for type 2 diabetes | |
Diabetes Metabolism: Research and Reviews--Chinese Diabetes Society special issue: a small but encouraging step toward the successful control of diabetes in China | |
Diabetic complications : new diagnostic tools and therapeutic advances | |
Diet and diabetes: a cornerstone for therapy | |
Dietary pattern and bone density changes in elderly women: a longitudinal study. | |
Editors' note to Raz and Eldor's commentary "Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms". Diabetes Metab Res Rev 2012 | |
Effect of ghrelin on bone mass density: the InChianti study | |
Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes. | |
The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial | |
Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy | |
Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal. | |
Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets | |
Fast publication, a must for a journal. | |
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. | |
Global status of diabetes prevention and prospects for action: A consensus statement | |
Glycemic variability in the development of cardiovascular complications in diabetes | |
A Goiter in Christ in Crucifixion. | |
Goiter in paintings by Rogier van der Weyden (1399-1464). | |
Gut microbiome response to short-term dietary interventions in reactive hypoglycemia subjects | |
High Prevalence of Autoimmune Diabetes and Poor Glycaemic Control among Adults in Madagascar: A Brief Report from a Humanitarian Health Campaign in Ambanja. | |
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline | |
HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus | |
Hypoglycemia and its management in primary care setting | |
Imaging in endocrinology | |
Immunotherapy of type 1 diabetes, c1989: | |
Impact of obesity on the increasing incidence of type 1 diabetes | |
The impact of type 2 diabetes on the development of tendinopathy | |
In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in Type 1 diabetes. | |
Incidence of Type 1 Diabetes Has Doubled in Rome and the Lazio Region in the 0- to 14-Year Age-Group: A 6-Year Prospective Study (2004-2009) | |
Increased carotid thickness in subjects with recently-diagnosed diabetes from rural Cameroon | |
Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: Action LADA 5 | |
Intervertebral disc degeneration: A focus on obesity and type 2 diabetes | |
Introduction into PPPM as a new paradigm of public health service: an integrative view | |
Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity | |
Is glucose control important for prevention of cardiovascular disease in diabetes? | |
Journey towards closing the loop | |
Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy | |
Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes | |
Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel | |
New concepts in pathology and treatment of autoimmune disorders | |
A new expression of diabetes: double diabetes | |
New technologies aiding dietary programmes for weight control: the oral glucose spray | |
No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial | |
Obesity and Glucose Metabolism | |
Obesity, autoimmunity, and double diabetes in youth | |
Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review | |
Osteoarthritis and type 2 diabetes: From pathogenetic factors to therapeutic intervention | |
Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes | |
Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience | |
A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes | |
Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials | |
Prevention of type 2 diabetes mellitus: is it feasible? | |
Proof-of-concept Raman spectroscopy study aimed to differentiate thyroid follicular patterned lesions. | |
Proposal for generating new beta cells in a muted immune environment for type 1 diabetes | |
Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women | |
Raman Spectroscopy Applied to Parathyroid Tissues: A New Diagnostic Tool to Discriminate Normal Tissue from Adenoma. | |
Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes | |
Recommendations for management of diabetes during Ramadan: update 2015. | |
Review of clinical trials: update on oral insulin spray formulation | |
Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: a cross sectional study | |
Scrotal asymmetry, varicocoele and the Riace Bronzes | |
Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin | |
Severe Hypophosphatemic Osteomalacia Secondary to Fanconi Syndrome Due to Adefovir: A Case Report | |
SLEEPING CUPID BY CARAVAGGIO: WHAT DIAGNOSIS? | |
SMART diabetes: the way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes). | |
Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes | |
Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control. | |
Treatment of reactive hypoglycemia with the macrobiotic Ma-pi 2 diet as assessed by continuous glucose monitoring: The MAHYP randomized crossover trial | |
Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial. | |
Type 1 diabetes at presentation: the scene changes | |
Ureteroarterial fistula from ureteral stump: a challenging case. | |
The use of a glucose spray device to control progression towards hypoglycaemia | |
The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study | |
Vitamin K and osteoporosis: Myth or reality? |